We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly, Samsung Biologics Partner to Expand Production of COVID-19 Antibody
Eli Lilly, Samsung Biologics Partner to Expand Production of COVID-19 Antibody
Eli Lilly and South Korea’s Samsung Biologics have forged a long-term partnership to expand the Indianapolis, Ind.-based drugmaker’s supply of COVID-19 neutralizing antibody treatments, amid concerns about shortages as coronavirus cases spike globally.